Login     Register  
    Home   |   Search   |   Director's Bio   |   About/Contact Us   |   Disclaimer  
BioEndeavor - Engaged Thinking  
 Home
 About BioEndeavor
 Engaged Thinking
 Engaged Thinking Blog
 Engaged Innovation Case Studies
 Engaged Thinking Academy
 Resources
 Engaged Innovation Directory
Go Back
  The Successes and Challenges of Open Source Pharmaceutical Innovation
BioEndeavor Network
10/07/2014 16:39


Journal coverIncreasingly, open-source–based alliances seek to provide broad access to data, research-based tools, preclinical samples and downstream compounds. The challenge is how to create value from open-source biopharmaceutical innovation. This value creation may occur via transparency and usage of data across the biopharmaceutical value chain as stakeholders move dynamically between open source and open innovation.

It is the author’s opinion that the assessment of when and how value creation will occur, through open-source biopharmaceutical innovation, is paramount. The key is to determine the metrics of value creation and the necessary technological, educational and legal frameworks to support the downstream outcomes of now big data-based open-source initiatives. The continued focus on the early-stage value creation is not advisable. Instead, it would be more advisable to adopt an approach where stakeholders transform open-source initiatives into open-source discovery, crowdsourcing and open product development partnerships on the same platform.
Read More: http://informahealthcare.com/doi/abs/10.1517/17460441.2014.905539?af=R
 
Go Back

© 2010-2017 BioEndeavor.Net
Privacy and Security Statement Disclaimer Adding Directory Profiles